Open AccessEfficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection
Author(s) -
Dayna T. Neo,
Aaron S. Devanathan,
JoAnn Kuruc,
Kara McGee,
John L. Schmitz,
Joe Sebastian,
Nicholas J. Shaheen,
Guido Ferrari,
Mehri McKellar,
Susan A. Fiscus,
Charles B. Hicks,
Kevin Robertson,
Angela D. M. Kashuba,
Joseph J. Eron,
David M. Margolis
Publication year - 2020
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002652
Subject(s) - etravirine , medicine , darunavir , ritonavir , neurocognitive , regimen , viral load , raltegravir , pharmacokinetics , maraviroc , tolerability , gastroenterology , antiretroviral therapy , human immunodeficiency virus (hiv) , adverse effect , immunology , psychiatry , cognition
The aim of this study was to evaluate penetration of antiretrovirals into compartments and efficacy of a dual, NRTI-sparing regimen in acute HIV infection (AHI).